Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-20

Clinical Trial Update: Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

View source ↗

Summary

A completed clinical trial evaluating genotype-guided, personalized dosing of cyclophosphamide for systemic lupus erythematosus, aiming to optimize efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lupus Erythematosus, Systemic, Adverse Effects | Status: COMPLETED